Many low- and middle-income countries (LMICs) face inconsistent supply of quality-assured vaccines and are therefore dependent on importation to fill the gaps in supply. It is recognized that local production can improve timely access and safeguard health security in vaccine supplies.
WHO Local Production and Assistance Unit (LPA) is organizing the Virtual cGMP Training Marathon for Vaccine Manufacturing in response to Member States’ requests for capacity building to address challenges and improve compliance to cGMP and regulatory requirements. This training welcomes the participation of vaccine manufacturers, biopharmaceutical manufacturers, manufacturers intending to produce vaccines, National Regulatory Agencies and officials from related government ministries such as Ministries of Health and Ministries of Industries.
From the 05 October to 11 November 2021, two topics will be delivered each week to provide the wide range of cGMP topics and minimize interruptions to business operations. Participants are encouraged to attend the full series of sessions to gain the most from the training. A certificate will be delivered to those passing the course requirements. For more details, please refer to the guidance for participants (available soon).
Interested participants might register here: Virtual cGMP Training Marathon for Vaccine Manufacturing registration of interest
For more information, please contact the LPA Unit Secretariat at: [email protected]
To continue reading this article please go to WHO .